Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
220.5 USD | -1.87% | -3.11% | -6.51% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.51% | 11.58B | |
+34.26% | 50.85B | |
+0.52% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.75% | 26.11B | |
-21.56% | 19.13B | |
+8.81% | 13.05B | |
+26.68% | 12.16B | |
+24.12% | 12.08B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Deutsche Bank Adjusts Charles River Laboratories International Price Target to $215 From $236, Maintains Buy Rating